/WALD
WALD Stock - Waldencast plc
Technology|Software - ApplicationNASDAQ
$1.94-1.77%
$0.04 (-1.77%) • Dec 19
70
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.20
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+67.5%upside
Target: $3.25
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for WALD
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1.92 – $1.96
TARGET (TP)$3.25
STOP LOSS$1.78
RISK/REWARD1:8.2
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-0.52
52W High$4.10
52W Low$1.48
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $273.87M | $218.14M | $166.13M | $142.47M | $94.43M |
| Gross Profit | $131.73M | $141.58M | $39.44M | $87.44M | $65.33M |
| Gross Margin | 48.1% | 64.9% | 23.7% | 61.4% | 69.2% |
| Operating Income | $-58,584,000 | $-81,931,000 | $-74,269,000 | $-1,625,000 | $528,000 |
| Net Income | $-42,443,000 | $-89,981,000 | $-116,624,000 | $-19,576,000 | $-2,370,000 |
| Net Margin | -15.5% | -41.2% | -70.2% | -13.7% | -2.5% |
| EPS | $-0.39 | $-0.89 | $-1.08 | $-0.45 | $-0.20 |
Company Overview
Waldencast Acquisition Corp. a skin care company, provides advanced skin care treatments. Its products are designed to help minimize the appearance of premature skin aging, skin damage, hyperpigmentation, acne, and sun damage primarily available through dermatologists, plastic surgeons, medical spas, and other skin care professionals. Its portfolio includes Obagi Medical that provides transformational skin care products formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines, and wrinkles and to protect and enhance skin tone and texture; and Obagi Clinical that offers skin care products designed to prevent the early signs of skin aging. The company was founded in 1988 and is based in White Plains, New York.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
7
88%
Hold / Neutral
1
13%
Sell / Underperform
0%
Analyst Consensus🟢 Bullish
7 Bullish1 Neutral/Bearish
Price Targets
$8
Average Target
↑ 314.1% Upside
Now
$3
Low
$8
Average
$13
High
Based on 9 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| November 25th 2025 | Telsey Advisory Group | Downgrade | Market Perform | $3 |
| April 22nd 2025 | Alliance Global Partners | Initiation | Buy | $5 |
| December 16th 2024 | TD Cowen | Initiation | Hold | $4.3 |
| October 25th 2024 | Canaccord Genuity | Initiation | Buy | $5 |
| May 1st 2024 | Telsey Advisory Group | Reiterated | Outperform | $8← $10 |
| July 24th 2023 | Raymond James | Downgrade | Market Perform | - |
| September 9th 2022 | DA Davidson | Initiation | Buy | $12 |
| August 22nd 2022 | Raymond James | Initiation | Outperform | $11 |
| August 17th 2022 | Jefferies | Initiation | Buy | $11 |
| July 19th 2022 | Telsey Advisory Group | Initiation | Outperform | $13 |
Earnings History & Surprises
WALDBeat Rate
0%
Last 6 quarters
Avg Surprise
-1941.6%
EPS vs Estimate
Beats / Misses
0/6
Last 12 quarters
Latest EPS
$-1.51
Q4 2025
EPS Surprise History
Q2 22
No data
Q3 22
-700.0%
$-0.06vs$0.01
Q2 23
No data
Q1 24
-7246.3%
$-0.49vs$-0.01
Q2 24
-1701.7%
$-0.64vs$0.04
Q4 24
-120.0%
$-0.11vs$-0.05
Q2 25
-612.3%
$-0.28vs$-0.04
Q4 25
-1269.5%
$-1.51vs$-0.11
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Dec 23, 2025 | $-0.11 | — | — | — |
Q4 2025 | Nov 24, 2025 | $-0.11 | $-1.51 | -1269.5% | ✗ MISS |
Q2 2025 | May 13, 2025 | $-0.04 | $-0.28 | -612.3% | ✗ MISS |
Q4 2024 | Nov 20, 2024 | $-0.05 | $-0.11 | -120.0% | ✗ MISS |
Q2 2024 | May 21, 2024 | $0.04 | $-0.64 | -1701.7% | ✗ MISS |
Q1 2024 | Jan 16, 2024 | $-0.01 | $-0.49 | -7246.3% | ✗ MISS |
Q2 2023 | Jun 29, 2023 | — | $-0.11 | — | — |
Q3 2022 | Aug 11, 2022 | $0.01 | $-0.06 | -700.0% | ✗ MISS |
Q2 2022 | May 16, 2022 | — | $-0.22 | — | — |
Q3 2021 | Aug 16, 2021 | — | $-0.22 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.10 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.10 | — | — |
Latest News
Waldencast shares are trading lower after the company reported mixed H1 financial results. Also, Telsey Advisory Group downgraded the stock from Outperform to Market Perform.
📉 NegativeBenzinga•Nov 25, 2025, 02:09 PM
Telsey Advisory Group Downgrades Waldencast to Market Perform, Maintains Price Target to $3
➖ NeutralBenzinga•Nov 25, 2025, 12:46 PM
Waldencast H1 Adj. EPS $(0.16) Misses $(0.07) Estimate, Sales $132.274M Beat $67.692M Estimate
📈 PositiveBenzinga•Nov 24, 2025, 10:41 PM
Waldencast shares are trading lower. The company reported Q2 financial results.
📉 NegativeBenzinga•Nov 24, 2025, 02:13 PM
CORRECTION: Waldencast Reported Q2 Revenue Of $66.83M Vs $63.31M YoY
📈 PositiveBenzinga•Nov 24, 2025, 02:13 PM
Waldencast Reported Q3 Revenue Of $66.83M Vs $63.31M YoY
📈 PositiveBenzinga•Nov 24, 2025, 11:49 AM
Reported Sunday, Waldencast Showcases Obagi Hyaluronic Acid Injectable Data Demonstrating Non-Inferiority To Voluma XC With High Patient Satisfaction
📈 PositiveBenzinga•Nov 17, 2025, 07:59 AM
Waldencast Plc Sells Its Rights To The "Obagi" Trademark In Japan To Rohto Pharmaceutical For $82.5M
📈 PositiveBenzinga•Nov 14, 2025, 10:09 PM
Waldencast Plans To Launch Obagi Saypha MagIQ In U.S. Market Alongside Other Important Skin Care Innovations In 2026
📈 PositiveBenzinga•Sep 10, 2025, 10:53 AM
Waldencast Says FDA Approves Obagi Saypha MagIQ Injectable Hyaluronic Acid Gel
📈 PositiveBenzinga•Sep 10, 2025, 10:50 AM
Waldencast Provides Business Update For H1 2025 Results; Obagi Medical Delivers H1 2025 Double-Digit Growth In Its Core Strategic Channels. Novaestiq Acquisition Doubles The Brand's Addressable Market In The U.S.; Company Launches An Exploration Of Strategic Alternatives To Enhance Shareholder Value; Company Postpones H1 2025 Earnings Release And Conference Call; The Company Now Expects Net Revenue Growth In The Low To Mid-single Digits
➖ NeutralBenzinga•Aug 18, 2025, 09:49 PM
Frequently Asked Questions about WALD
What is WALD's current stock price?
Waldencast plc (WALD) is currently trading at $1.94 per share. The stock has moved -1.77% today.
What is the analyst price target for WALD?
The average analyst price target for WALD is $3.25, based on 1 analyst.
What sector is Waldencast plc in?
Waldencast plc operates in the Technology sector, specifically within the Software - Application industry. The company is traded on the NASDAQ exchange.
What is WALD's market cap?
Waldencast plc has a market capitalization of $0.22 billion, making it a small-cap company.
Does WALD pay dividends?
No, Waldencast plc does not currently pay a dividend to shareholders.
Similar Stocks
Technology SectorAEYE
AudioEye, Inc.
$11.01
Mkt Cap: $0.1B
ARBE
Arbe Robotics Ltd.
$1.18
Mkt Cap: $0.1B
DUOT
Duos Technologies Group, Inc.
$9.54
Mkt Cap: $0.2B
EB
Eventbrite, Inc.
$4.43
Mkt Cap: $0.4B
IMMR
Immersion Corporation
$6.45
Mkt Cap: $0.2B
MRT
Marti Technologies, Inc.
$2.23
Mkt Cap: $0.2B
ONTF
ON24, Inc.
$5.79
Mkt Cap: $0.2B
PERF
Perfect Corp.
$1.81
Mkt Cap: $0.2B
SVCO
Silvaco Group, Inc. Common Stock
$4.25
Mkt Cap: $0.1B
TCX
Tucows Inc.
$23.50
Mkt Cap: $0.3B
Explore stocks similar to WALD for comparison